Bilateral Panuveitis at Etanercept Initiation for Juvenile Idiopathic Arthritis
Kaouther Ben Abdelghani, Marwa Slouma, Rym Hajri and 2 more
European Journal of Case Reports in Internal Medicine · 2014
doi:10.12890/2014_000036 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Introduction: Uveitis is a well-known extra-rheumatological manifestation of juvenile idiopathic arthritis (JIA). Tumour necrosis factor(TNF) has been used to treat uveitis associated with inflammatory diseases. A new-onset uveitis under anti-TNF therapy is uncommon. Case presentation: A 12-year-old male, affected since the age of 6 years, by a severe form of polyarticular JIA. When etanercept was started, hepresented panuveitis bilaterally, so we switched to infliximab with good response. Conclusions: The TNF-soluble receptor could be considered as a possible promoter in inducing endogenous new-onset uveitis in JIA.
Abstract licence: CC BY-NC-ND
References9
9 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.